Propofol attenuates endotoxin-induced endothelial cell injury, angiotensin-converting enzyme shedding, and lung edema

Anesthesia and Analgesia

Volumn 105, Issue 5, 2007, Pages 1363-1370

  Votta Velis, E Gina ^a   Minshall, Richard D ^a   Visintine, David J ^a   Castellon, Maricela ^a   Balyasnikova, Irina V ^a,b  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTOXIN; MONOCLONAL ANTIBODY; PROPOFOL;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ARTICLE; BODY WEIGHT; CELL DAMAGE; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; LUNG EDEMA; LUNG WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE;

EID: 37349089709     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000281144.06703.0d     Document Type: Article

References (49)

1. Soffer RL. Angiotensin-converting enzyme and the regulation of vasoactive peptides. Annu Rev Biochem 1976;45:73-94
2. Caldwell PR, Seegal BC, Hsu KC, Das M, Soffer RL. Angiotensin-converting enzyme: vascular endothelial localization. Science 1976;191:1050-1
3. Franke FE, Danilov SM. CD143 workshop: angiotensin-Iconverting enzyme (CD143) on endothelial cells in normal and in pathological conditions. In: Kishimoto T, Kikutani H, von dem Borne AEG, Goyert SM, Mason DY, Miyasaka M, Moretta L, Okumura K, Shaw S, Springer TA, Sugamura K, Zola H, eds. Leukocyte typing VI. New York: Garland Publishing, 1997:749-51
4. Danilov SM, Gavrilyuk VD, Franke FE, Pauls K, Harshaw DW, McDonald TD, Miletich DJ, Muzykantov VR. Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting. Am J Physiol Lung Cell Mol Physiol 2001;280:L1335-47
5. Hollinger MA, Giri SN, Patwell S, Zuckerman JE, Gorin A, Parsons G. Effect of acute lung injury on angiotensin converting enzyme in serum, lung lavage, and effusate. Am Rev Respir Dis 1980;121:373-6
6. Fourrier F, Chopin C, Wallaert B, Wattre P, Mangalaboyi J, Durocher A, Dubois D, Wattel F. Angiotensin-converting enzyme in human adult respiratory distress syndrome. Chest 1983;83:593-7
7. Kelley J. Lavage angiotensin-converting enzyme as a marker of lung injury. Am Rev Respir Dis 1988;137:531-4
8. Nukiwa T, Matsuoka R, Takagi H, Ishii Y, Arai T, Kira S. Responses of serum and lung angiotensin-converting enzyme activities in the early phase of pulmonary damage induced by oleic acid in dogs. Am Rev Respir Dis 1982;126:1080-6
9. Gorin AB, Hasagawa G, Hollinger M, Sperry J, Zuckerman J. Release of angiotensin converting enzyme by the lung after Pseudomonas bacteremia in sheep. J Clin Invest 1981;68:163-70
10. Hollinger M. Serum angiotensin-converting enzyme. Status report on its diagnostic significance in pulmonary disease. Chest 1983;83:589-90
11. Atochina EN, Balyasnikova IV, Danilov SM, Granger DN, Fisher AB, Muzykantov VR. Immunotargeting of catalase to ACE or ICAM-1 protects perfused rat lungs against oxidative stress. Am J Physiol 1998;275:L806-17
12. Danilov SM, Muzykantov VR, Martynov AV, Atochina EN, Sakharov IYu, Trakht IN, Smirnov VN. Lung is the target organ for the monoclonal antibodies to angiotensin-converting enzyme. Lab Invest 1991;64:118-24
13. Danilov S, Atochina E, Hiemisch H, Churak-ova T, Moldobayeva A, Sakharov I, Deichman G, Ryan U, Muzykantov VR. Interaction of mAb to angiotensin- converting enzyme (ACE) with antigen in vitro and in vivo: antibody targeting to the lung induces ACE antigenic modulation. Int Immunol 1994;6:1153-60
14. Muzykantov VR, Danilov SM. Targeting of radiolabelled monoclonal antibody against angiotensin-converting enzyme to the pulmonary vasculature. In: Torchilin VP, ed. Handbook of targeting delivery of imaging agents. Boca Raton, FL: CRC, 1995:465-86
15. Muzykantov VR, Puchnina EA, Atochina EN, Hiemish H, Slinkin MA, Meertsuk FE, Danilov SM. Endotoxin reduces specific pulmonary uptake of radiolabeled monoclonal antibody to angiotensin-converting enzyme. J Nucl Med 1991;3:2453-60
16. Balyasnikova IV, Visintine DJ, Gunnerson HB, Paisansathan C, Baughman VL, Minshall RD, Danilov SM. Propofol attenuates lung endothelial injury induced by ischemia-reperfusion and oxidative stress. Anesth Analg 2005;100:929-36
17. Murphy PG, Myers DS, Davies MJ, Webster NR, Jones JG. The antioxidant potential of propofol (2,6-diisopropylphenol). Br J Anaesth 1992;68:613-18
18. Kahraman S, Demiryurek AT. Propofol is a peroxynitrite scavenger. Anesth Analg 1997;84:1127-9
19. Green TR, Bennett SR, Nelson VM. Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicol Appl Pharmacol 1994;129:163-9
20. Aoki H, Mizobe T, Nozuchi S, Hiramatsu N. In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation. Anesthesiology 1998;88:362-70
21. Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, Niwa Y. Propofol inhibits human neutrophil functions. Anesth Analg 1998;87:695-700
22. Taniguchi T, Kanakura H, Yamamoto K. Effects of posttreatment with propofol on mortality and cytokine responses to endotoxin-induced shock in rats. Crit Care Med 2002;30:904-7
23. Balyasnikova IV, Metzger R, Visintine DJ, Dimasius V, Sun ZL, Berestetskaya YV, McDonald TD, Curiel DT, Minshall RD, Danilov SM. Selective rat lung endothelial targeting with a new set of monoclonal antibodies to angiotensin I-converting enzyme. Pulm Pharmacol Ther 2005;18:251-67
24. Friedland J, Silverstein EA. A sensitive fluorometric assay for serum angiotensin-converting enzyme. Am J Clin Pathol 1976;66:416-24
25. Balyasnikova IV, Danilov SM, Muzykantov VR, Fisher AB. Modulation of angiotensin-converting enzyme in cultured human vascular endothelial cells. In Vitro Cell Dev Biol 1998;34:545-54
26. John TA, Vogel SM, Tiruppathi C, Malik AB, Minshall RD. Quantitative analysis of albumin uptake and transport in the rat microvessel endothelial monolayer. Am J Physiol Lung Cell Mol Physiol 2003;284:L187-96
27. Balyasnikova IV, Gavrilyuk VD, McDonald TD, Berkowitz D, Danilov SM. In vitro model of lung endothelium targeting using a cell line expressing angiotensin-converting enzyme. Tumor Target 1999;4:70-83
28. Parrillo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471-7
29. Marik PE. Propofol: therapeutic indications and side-effects. Curr Pharm Des 2004;10:3639-49
30. Taniguchi T, Kanakura H, Takemoto Y, Kidani Y, Yamamoto K. Effects of ketamine and propofol on the ratio of interleukin-6 to interleukin-10 during endotoxemia in rats. Tohoku J Exp Med 2003;200:85-92
31. Takao Y, Mikawa K, Nishina K, Obara H. Attenuation of acute lung injury with propofol in endotoxemia. Anesth Analg 2005;100:810-16
32. Gao J, Zeng BX, Zhou LJ, Yuan SY. Protective effects of early treatment with propofol on endotoxin-induced acute lung injury in rats. Br J Anaesth 2004;92:277-9
33. Kwak SH, Choi JI, Park JT. Effects of propofol on endotoxin-induced acute lung injury in rabbit. J Korean Med Sci 2004;19:55-61
34. Frank L, Summerville J, Massaro D. Protection from oxygen toxicity with endotoxin. Role of the endogenous antioxidant enzymes of the lung. J Clin Invest 1980;65:1104-11
35. Liu MC, Tsai PS, Yang CH, Liu CH, Chen CC, Huang CJ. Propofol significantly attenuates iNOS, CAT-2, and CAT-2B transcription in lipopolysaccharide-stimulated murine macrophages. Acta Anaesthesiol Taiwan 2006;44:73-81
36. Chen RM, Wu GJ, Tai YT, Sun WZ, Lin YL, Jean WC, Chen TL. Propofol reduces nitric oxide biosynthesis in lipopolysaccharide-activated macrophages by downregulating the expression of inducible nitric oxide synthase. Arch Toxicol 2003;77:418-23
37. Chen RM, Chen TG, Chen TL, Lin LL, Chang CC, Chang HC, Wu CH. Anti-inflammatory and antioxidative effects of propofol on lipopolysaccharide- activated macrophages. Ann N Y Acad Sci 2005;1042:262-71
38. Gordon BR, Parker TS, Levine DM, Feuerbach F, Saal SD, Sloan BJ, Chu C, Stenzel KH, Parrillo JE, Rubin AL. Neutralization of endotoxin by a phospholipid emulsion in healthy volunteers. J Infect Dis 2005;191:1515-22
39. Flegel WA, Baumstark MW, Weinstock C, Berg A, Northoff H. Prevention of endotoxin-induced monokine release by human low- and high-density lipoproteins and by apolipoprotein A-I. Infect Immun 1993;61:5140-6
40. van der Poll T, Braxton CC, Coyle SM, Boermeester MA, Wang JC, Jansen PM, Montegut WJ, Calvano SE, Hack CE, Lowry SF. Effect of hypertriglyceridemia on endotoxin responsiveness in humans. Infect Immun 1995;63:3396-400
41. Atochina EN, Muzykantov VR, Al-Mehdi A, Danilov SM, Fisher A. Lung ischemia/reperfusion releases angiotensin-converting enzyme from the pulmonary endothelium. Am J Respir Crit Care Med 1997;156:1114-19
42. Muzykantov V, Puchnina E, Atochina E, Sakharov I, Danilov S. Evaluation of the lung microvascular status using radiolabeled monoclonal antibody to angiotensin-converting enzyme. In: Strano A, Novo S, eds. Advances in vascular pathology. New York: Elsevier, 1989:1195-200
43. Tominaga M, Song GB, Ikemoto F, Yamamoto K. Effect of oxidation on the activity of angiotensin converting enzyme in the rat kidney, heart and brain. Clin Exp Hypertens A 1988;10:1271-8
44. Brigham KL, Meyrick B, Berry LC Jr, Repine JE. Antioxidants protect cultured bovine lung endothelial cells from injury by endotoxin. J Appl Physiol 1987;63:840-50
45. Danilov SM, Martynov AV, Klibanov AL, Slinkin MA, Sakharov IYu, Malov AG, Sergienko VB, Vedernikov AYu, Muzykantov VR, Torchilin VP. Radioimmunoimaging of lung vessels: an approach using Indium-111-labeled monoclonal antibody to angiotensin-converting enzyme. J Nucl Med 1989;30:1686-92
46. Watanabe K, Lam G, Keresztes RS, Jaffe EA. Lipopolysaccharides decrease angiotensin converting enzyme activity expressed by cultured human endothelial cells. J Cell Physiol 1992;150:433-9
47. Watanabe K, Jaffe EA. Comparison of the potency of various serotypes of E. coli lipopolysaccharides in stimulating PGI2 production and suppressing ACE activity in cultured human umbilical vein endothelial cells. Prostaglandins Leukot Essent Fatty Acids 1993;49:955-8
48. Bannerman DD, Goldblum SE. Mechanism of bacterial lipopolysaccharide- induced endothelial apoptosis. Am J Physiol Lung Cell Mol Physiol 2003;284:L899-914
49. Laskin DL, Heck DE, Gardner CR, Feder LS, Laskin JD. Distinct pattern of nitric oxide production in hepatic macrophages and endothelial cells following acute exposure of rats to endotoxin. J Leukoc Biol 1994;56:751-8